# Aluna

> Aluna is a San Francisco digital health company that turns daily breathing into data. Its FDA-cleared, palm-sized spirometer pairs with a gamified app and a clinician dashboard so people with asthma, COPD and cystic fibrosis - and their doctors - can track lung function (FEV1) at home and catch trouble before it becomes an emergency. Founded by three UC Berkeley alumni and originally named Knox Medical Diagnostics, Aluna raised about $27M total, including a $15.3M Series B in 2023, and was acquired by Huma in May 2025.

- **Founded:** 2016
- **Headquarters:** San Francisco, California, United States
- **Founders:** Charvi Shetty (Co-Founder & CEO), Inderjit Jutla (Co-Founder), Huyson Lam (Co-Founder)
- **Team size:** ~89 employees
- **Products:** Aluna Digital Spirometer, Aluna App, Aluna Clinician Dashboard
- **Notable:** Received FDA clearance for its portable spirometer, app and clinician dashboard, Won National Science Foundation funding for its respiratory management tool, Made hospital-grade spirometry available at home during COVID-19

## Products & services

- **Aluna Digital Spirometer** — An FDA-cleared, portable, hospital-grade spirometer that connects to a smartphone over Bluetooth, charges via USB, and uses a removable, washable mouthpiece for at-home lung function testing.
- **Aluna App** — A companion mobile app that automatically tracks FEV1% over time alongside symptoms, medication, exercise and environmental factors, using games, challenges and rewards to keep daily testing habits sticky.
- **Aluna Clinician Dashboard** — A provider-facing platform that lets doctors review patients' FEV1 scores and trends in real time, supporting remote patient monitoring and earlier intervention.

## Achievements

- Received FDA clearance for its portable spirometer, app and clinician dashboard
- Won National Science Foundation funding for its respiratory management tool
- Made hospital-grade spirometry available at home during COVID-19
- Reported ~10x year-over-year patient growth around its 2023 Series B
- Raised roughly $27M total, including a $15.3M Series B led by Matrix Partners
- Acquired by Huma in May 2025, helping form one of the largest respiratory RPM footprints in the US

## Latest updates

- **2025-05** — Huma acquired Aluna (Knox Medical Diagnostics); Aluna's products to relaunch on the Huma Cloud Platform and pursue FDA Class II classification.
- **2023-01** — Closed a $15.3M Series B led by Matrix Partners to grow its respiratory management platform among doctors and patients.
- **2022-10** — CEO Charvi Shetty detailed Aluna's FDA-cleared at-home spirometer approach in a Medgadget interview.

## Links

- Website: https://alunacare.com
- LinkedIn: https://www.linkedin.com/company/alunacare
- Twitter/X: https://twitter.com/alunacare
- Instagram: https://www.instagram.com/alunacare/
- Facebook: https://www.facebook.com/alunacare

---

Profile page: https://yespress.io/aluna
Published by YesPress — https://yespress.io
Last updated: 2026-06-16